We are live on ! Find out more
RMTI icon

Rockwell Medical

34 hedge funds and large institutions have $3.32M invested in Rockwell Medical in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

337% more capital inflows, than outflows

Capital inflows: $1.22M | Capital outflows: $279K

3.19% more ownership

Funds ownership: 21.13% → 24.31% (+3.2%)

6% less funds holding

Funds holding: 36 → 34 (-2)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
34
Holders Change
-2
Holders Change %
-5.56%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
11
Closed
6
Calls
$46​K
Puts
–
Net Calls
+$46​K
Net Calls Change
-⁠$59​K

RMTI Hedge Fund Activity: Q3 2022 in Review

34 of the 5,834 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q3 2022, worth a combined $3.32M — up 36% from $2.45M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of RMTI and 4 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 8 added.

The largest buyer was Armistice Capital, adding an estimated $1.14M. The largest seller was Vanguard Group, cutting an estimated $70.9K.

  • 34 institutional investors held Rockwell Medical (RMTI) as of Q3 2022, down from 36 in Q2 2022.
  • Funds reported $3.32M of Rockwell Medical stock for Q3 2022, up 36% quarter-over-quarter.
  • 4 funds opened new Rockwell Medical positions in Q3 2022 and 6 closed out, a net change of -2 holders.
  • The largest Rockwell Medical buyer in Q3 2022 was Armistice Capital, an estimated $1.14M added.
  • The largest Rockwell Medical seller in Q3 2022 was Vanguard Group, an estimated $70.9K sold.

Based on aggregated 13F filings for Q3 2022.